Cardinal Health, Inc. – Consensus Indicates Potential -1.5% Downside

DirectorsTalk Interviews

Cardinal Health, Inc. with ticker code (CAH) have now 13 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The range between the high target price and low target price is between 80 and 56 and has a mean target at 69.54. With the stocks previous close at 70.63 this would indicate that there is a downside of -1.5%. The day 50 moving average is 62.01 while the 200 day moving average is 56.08. The market cap for the company is $19,046m. Visit the company website at: https://www.cardinalhealth.com

The potential market cap would be $18,752m based on the market concensus.

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Share on:

Latest Company News

CMC Markets CEO Peter Cruddas buys £139,000 in shares

CMC Markets CEO Lord Peter Cruddas has purchased 23,011 shares for approximately £139,000 and intends to invest up to £5 million in the company, including the shares acquired today.

MeyGen accounts for more than 80% of global tidal stream generation

MeyGen generated 13.1 GWh in 2025, representing more than 80% of global tidal stream electricity generation. Its longest-operating turbine is undergoing inspection after more than seven and a half years of continuous operation.

The role of structured investments

UK life insurers are exploring private credit and securitised investments to match long-term liabilities and manage capital requirements, with regulatory rules and asset structuring shaping the opportunities available to insurers and asset managers.

Finseta to meet industry partners at iFX EXPO Asia 2026 in Hong Kong

Finseta is set to attend iFX EXPO Asia 2026 in Hong Kong, where its Head of Alternative Banking will meet partners and industry leaders to discuss developments in alternative banking solutions and potential opportunities for collaboration.

Corero Network Security builds on recognition in global DDoS protection market

Corero Network Security has strengthened its position in the Stars quadrant of MarketsandMarkets’ 2026 DDoS Protection and Mitigation Market report for the second consecutive year, reflecting continued product development and customer confidence.

Drax adds interactive map to Biomass Tracker

Drax has introduced an interactive map to its Biomass Tracker, providing information on sourcing locations, transportation routes and carbon emissions, alongside updated first-quarter 2026 data.

    Search